SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 288 filers reported holding SEATTLE GENETICS INC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,527,000 | +15.4% | 23,000 | -9.0% | 0.01% | +40.0% |
| Q1 2018 | $1,323,000 | -10.9% | 25,280 | -8.9% | 0.01% | -28.6% |
| Q4 2017 | $1,485,000 | +11.9% | 27,759 | +13.8% | 0.01% | 0.0% |
| Q3 2017 | $1,327,000 | +15.0% | 24,385 | +9.3% | 0.01% | 0.0% |
| Q2 2017 | $1,154,000 | -40.5% | 22,318 | -37.8% | 0.01% | -53.3% |
| Q3 2016 | $1,938,000 | +5.9% | 35,900 | -20.8% | 0.02% | +7.1% |
| Q2 2016 | $1,830,000 | -11.1% | 45,300 | -22.8% | 0.01% | -17.6% |
| Q1 2016 | $2,059,000 | -64.2% | 58,700 | -54.2% | 0.02% | -10.5% |
| Q4 2015 | $5,754,000 | +0.5% | 128,200 | -13.7% | 0.02% | -36.7% |
| Q3 2015 | $5,726,000 | -43.8% | 148,500 | -29.4% | 0.03% | -50.0% |
| Q2 2015 | $10,184,000 | +222.6% | 210,400 | +135.6% | 0.06% | +150.0% |
| Q1 2015 | $3,157,000 | +427.9% | 89,300 | +379.9% | 0.02% | +500.0% |
| Q4 2014 | $598,000 | +122.3% | 18,608 | +215.4% | 0.00% | +100.0% |
| Q1 2014 | $269,000 | -14.6% | 5,900 | -41.0% | 0.00% | +100.0% |
| Q2 2013 | $315,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |